Smith & Nephew Plc Stock price

Equities

SN.

GB0009223206

Medical Equipment, Supplies & Distribution

Market Closed - London Stock Exchange 11:35:10 2023-12-01 am EST Intraday chart for Smith & Nephew Plc 5-day change 1st Jan Change
1,035.50 GBX +1.17% +1.07% -6.67%
Sales 2023 * 5,545 M Sales 2024 * 5,813 M Capitalization 11.45 B
Net income 2023 * 461 M Net income 2024 * 622 M EV / Sales 2023 *
2,52x
Net Debt 2023 * 2,534 M Net Debt 2024 * 2,315 M EV / Sales 2024 *
2,37x
P/E ratio 2023 *
26,9x
P/E ratio 2024 *
19,2x
Employees 19,000
Yield 2023 *
2,78%
Yield 2024 *
3,02%
Free-Float 99.31%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.17%
1 week+1.07%
Current month+1.17%
1 month+12.14%
3 months-2.72%
6 months-13.82%
Current year-6.67%
More quotes
1 week
1 012.00
Extreme 1012
1 037.50
1 month
974.78
Extreme 974.776
1 043.50
Current year
887.00
Extreme 887
1 316.75
1 year
887.00
Extreme 887
1 316.75
3 years
887.00
Extreme 887
1 681.50
5 years
887.00
Extreme 887
2 023.00
10 years
816.50
Extreme 816.5
2 023.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 2022
Director of Finance/CFO 52 2020
Compliance Officer - 1999
Members of the board TitleAgeSince
Director/Board Member 64 2017
Director/Board Member 59 2014
Director/Board Member 63 2020
More insiders
Date Price Change Volume
23-12-01 1,035.50 +1.17% 2,062,490
23-11-30 1,023.50 +0.20% 5,403,513
23-11-29 1,021.50 +0.05% 2,571,471
23-11-28 1,021.00 -0.05% 3,555,214
23-11-27 1,021.50 -0.29% 1,553,400

Delayed Quote London Stock Exchange, December 01, 2023 at 11:35 am EST

More quotes
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipments. Net sales break down by activity sector as follows: - orthopedic surgery (40.5%): primarily orthopedic implants (hips, knees and shoulders) ; - sports medicine, arthroscopy and cervicofacial surgery (30.5%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound care (29%): skin grafts for major burns victims, treatments for leg ulcers, etc. The United States accounts for 53% of net sales.
Calendar
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
13.13USD
Average target price
16.21USD
Spread / Average Target
+23.48%
Consensus
  1. Stock
  2. Equities
  3. Stock Smith & Nephew Plc - London Stock Exchange
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer